No. of Recommendations: 3
Although I realize the point of Bill Mann's article was not to discuss Hemispherx Biopharma, per se, that the larger point of it was to show that people are still easily swayed by so-called analyst coverage, I was intrigued by the dubiousness of their press release regarding the "royal family" and did a Google search of the company.

Interestingly, it appears the company has run afoul of the FDA a couple of times in the past for its press releases, website and promotional materials. Here's a letter the FDA sent to the company back in July, 2000, admonishing them for promoting their drug Ampligen:

It notes, "We previously issued an untitled letter, dated October 15, 1998, to Hemisphcrx for promoting Ampligen as safe or effective while the product was under investigation....However, notwithstanding your assurances, you continue to promote Ampligen as safe and effective prior to approval in your press releases and on your Internet website."

I looked around their website briefly but did not find any Ampligen "promotion," but I did notice that the Taglich report was laden with it. And as the Hemispherx pays the company a monthly fee to produce such reports, I wonder if that's not coming awfully close to flouting the FDA's directive...again!

Thanks, Bill, for pointing out this egregious case study.

Print the post  


What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.